What are the diagnostic criteria for overt and subclinical hypothyroidism, including TSH and free T4 thresholds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Hypothyroidism

Overt hypothyroidism is diagnosed when TSH is elevated (typically >10 mIU/L) with a low free T4 (<0.8 ng/dL or 10.3 pmol/L), while subclinical hypothyroidism requires an elevated TSH (>4.5 mIU/L) with normal free T4 (0.8-2.0 ng/dL or 10.3-25.7 pmol/L). 1, 2

Overt Hypothyroidism

The diagnosis is straightforward when both criteria are met:

  • TSH elevated above normal range (generally >10 mIU/L indicates more severe disease)
  • Free T4 below reference range (<0.8 ng/dL or <10.3 pmol/L) 1, 2

In some cases, patients with hypothyroid symptoms and TSH >10 mIU/L but low-normal free T4 have also been classified as having overt hypothyroidism 1. This reflects the clinical reality that symptomatic patients with markedly elevated TSH warrant treatment even if free T4 hasn't yet fallen below the reference range.

Subclinical Hypothyroidism

This diagnosis requires both of the following:

  • TSH above 4.5 mIU/L (the upper limit of the normal reference range of 0.45-4.5 mIU/L) 1
  • Free T4 within normal range (0.8-2.0 ng/dL or 10.3-25.7 pmol/L) 1

Critical Diagnostic Considerations

Confirm the diagnosis before labeling a patient: If initial TSH is elevated, repeat TSH along with free T4 measurement at minimum 2 weeks but no longer than 3 months after initial assessment 1. This is essential because TSH can be transiently elevated in approximately 50% of cases, with spontaneous normalization occurring 3.

The TSH range of 2.5-4.5 mIU/L is controversial. While this may identify individuals with earliest-stage hypothyroidism or Hashimoto's thyroiditis, there is no evidence for associated adverse consequences. This range can also reflect technical assay problems, abnormal TSH isoforms, or heterophilic antibodies 1. Do not diagnose subclinical hypothyroidism in this range without compelling clinical context.

Severity Stratification in Subclinical Hypothyroidism

The degree of TSH elevation matters clinically:

  • TSH 4.5-10 mIU/L: Mild subclinical hypothyroidism; approximately 75% of patients with elevated TSH fall in this range 1
  • TSH >10 mIU/L: More severe subclinical hypothyroidism with stronger indication for treatment 1, 4

Essential Exclusions Before Diagnosis

Rule out these conditions that can falsely elevate TSH:

  • Assay interference (occurs in ~1% of cases): human antimouse antibodies (HAMA), thyroid hormone autoantibodies, rheumatoid factor, biotin supplementation 5, 6
  • Nonthyroidal illness (euthyroid sick syndrome) 1
  • Recent treatment for hyperthyroidism (delayed TSH recovery) 1
  • Medications: dopamine, glucocorticoids, dobutamine 1
  • Thyroid hormone resistance (check serum α-GSU and family history) 5
  • Central hypothyroidism (TSH may be normal or slightly elevated, but free T4 is low) 2

Biotin is a critical pitfall: This common supplement interferes with immunoassays, causing falsely high T4/T3 and low TSH, potentially masking true hypothyroidism or creating false diagnoses. Patients should discontinue biotin at least 2-3 days before testing 5.

Diagnostic Algorithm

  1. Measure TSH first in at-risk patients
  2. If TSH >4.5 mIU/L: Measure free T4
  3. If free T4 is low: Diagnose overt hypothyroidism
  4. If free T4 is normal: Repeat TSH and free T4 in 2 weeks to 3 months to confirm persistent elevation 1
  5. If TSH remains elevated on repeat testing:
    • Check for symptoms of hypothyroidism
    • Assess for goiter, prior thyroid treatment, family history
    • Consider measuring anti-TPO antibodies (predicts 4.3% annual progression to overt disease vs 2.6% without antibodies) 1
    • Review medications and supplements (especially biotin)
    • Ensure same laboratory and assay method for serial measurements 5

Special Populations

Elderly patients (>70 years): TSH levels physiologically increase with age. The diagnosis of subclinical hypothyroidism is likely overdiagnosed and overtreated in this population 3. Consider higher TSH thresholds before diagnosing disease.

Pregnant women: Require different TSH reference ranges specific to trimester and warrant special diagnostic and treatment considerations 7.

Epidemiology Context

Subclinical hypothyroidism affects 4-8.5% of the U.S. adult population without known thyroid disease, increasing to 20% in women over 60 years 1. Progression to overt hypothyroidism occurs in 2-5% annually, with higher rates when TSH is elevated and anti-TPO antibodies are present 1, 4.

References

Related Questions

How should a patient with normal TSH and free T4 but elevated thyroid antibodies be managed?
Can you provide a diagram of the various thyroid function profiles showing the typical TSH and free T4 levels for each condition?
How should I manage a patient with elevated thyroid antibodies, ultrasound evidence of thyroiditis, and a TSH of 3.7 mIU/L?
How should I evaluate and manage a 40-year-old female with six months of left-sided head, neck, and shoulder pain accompanied by photophobia, phonophobia, choking sensation in bright light, and insomnia, who has hypothyroidism treated with levothyroxine 50 µg, borderline elevated thyroid‑stimulating hormone, low‑normal free T4 and T3, mildly elevated AST and ALT, and normal vital signs?
How should a 51-year-old woman with a thyroid panel showing T3 4.01 pg/mL (upper‑normal), free T4 0.89 ng/dL (low‑normal), and TSH 6.01 mIU/L (mildly elevated) be managed?
In a patient who was on sertraline 100 mg with a QT interval of 470 ms, which was tapered and discontinued, and now presents with low mood and agitation, what alternative antidepressant medication can be prescribed that does not prolong the QT interval?
What are the recommended guidelines for initiating and titrating antihypertensive therapy in adults, including first-line drug choices and special considerations for diabetes, chronic kidney disease, or heart failure?
In a 67-year-old woman with a long-standing recurrent unexplained cough, no smoking history, normal chest imaging, and normal pulmonary function tests, what are the possible causes and recommended treatment options?
What is the most effective drug for anxiety with psychotic features?
Can an 80-year-old patient with a remote history of tuberculosis at age 4 safely use intranasal corticosteroids?
What taper schedule should be used to transition a patient from sertraline 100 mg to escitalopram (Lexapro) 20 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.